Sign in to view content

Ixoberogene Soroparvovec (Ixo-vec) IVT Gene Therapy for Neovascular AMD: First Time 26-Week Interim Analysis Results from the Phase 2 LUNA Study

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2024

Related

Robotic Surgery as a Delivery Tool for Novel Retinal Therapies
Lyndon da Cruz, MBBS, BA, MA, FRCOphth, PhD, FRACO
Updates from the Field
2019
AAV-RPGR Gene Therapy for RPGR-Associated X-Linked Retinitis Pigmentosa: 6-month Results From a Phase 1/2 Clinical Trial
Michel Michaelides, BSc, MB BS, MD(Res), FRCOphth, FACS
Updates from the Field
2020
Gene Therapy in Pediatric Retina Patients at the Bascom Palmer Eye Institute: What I Have Learned
Audina M. Berrocal, MD FASRS
Annual Meeting Talks
2019

Category: AMD-Neovascular

See more